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Insufficient advances in the development of effective therapeutic treatments of sporadic
Alzheimer’s Disease (sAD) to date are largely due to the lack of sAD-relevant animal
models. While the vast majority of models do recapitulate AD’s hallmarks of plaques
and tangles by virtue of tau and/or beta amyloid overexpression, these models do not
reflect the fact that in sAD (unlike familial AD) these genes are not risk factors per se and
that other mechanisms like oxidative stress, metabolic dysregulation and inflammation
play key roles in AD etiology. Here we characterize and propose the Fus1 KO mice
that lack a mitochondrial protein Fus1/Tusc2 as a new sAD model. To establish sAD
relevance, we assessed sAD related deficits in Fus1 KO and WT adult mice of 4–5
months old, the equivalent human age when the earliest cognitive and olfactory sAD
symptoms arise. Fus1 KO mice showed oxidative stress (increased levels of ROS,
decreased levels of PRDX1), disruption of metabolic homeostasis (decreased levels of
ACC2, increased phosphorylation of AMPK), autophagy (decreased levels of LC3-II),
PKC (decreased levels of RACK1) and calcium signaling (decreased levels of Calb2) in
the olfactory bulb and/or hippocampus. Mice were behaviorally tested using objective
and accurate video tracking (Noldus), in which Fus1 KO mice showed clear deficits in
olfactory memory (decreased habituation/cross-habituation in the short and long term),
olfactory guided navigation memory (inability to reduce their latency to find the hidden
cookie), spatial memory (learning impairments on finding the platform in the Morris water
maze) and showed more sleep time during the diurnal cycle. Fus1 KO mice did not show
clear deficits in olfactory perception (cross-habituation), association memory (passive
avoidance) or in species-typical behavior (nest building) and no increased anxiety (open
field, light-dark box) or depression/anhedonia (sucrose preference) at this relatively young
age. These neurobehavioral deficits of the Fus1 KO mice at this relatively young age are
highly relevant to sAD, making them suitable for effective research on pharmacological
targets in the context of early intervention of sAD.
Keywords: sporadic Alzheimer’s Disease, Fus1/Tusc2, Fus1 KO, olfaction, hippocampus, oxidative stress, Morris
water maze, olfactory bulb
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INTRODUCTION
Alzheimer’s disease (AD) accounts for more than 80% of
dementia incidences and is one of the most common
neurodegenerative diseases worldwide (Kumar et al., 2015).
AD is a complex disorder that can be subdivided into familial
and sporadic cases (Piaceri et al., 2013). Familial AD (fAD)
has been associated with mutations in three genes; amyloid
precursor protein (APP) (Goate et al., 1991), presenilin 1
(PSEN1) (Sherrington et al., 1995), and presenilin 2 (PSEN2)
(Levy-Lahad et al., 1995). fAD predominantly displays between
the ages of 35–70 years and is defined as early onset (Ryan and
Rossor, 2010). Sporadic AD (sAD), which encompasses∼90% of
all AD cases (Anand et al., 2014) is determined by both genetic
and environmental factors and usually develops in patients older
than 70 years, known as late onset (Bird, 2008). Patients with
AD present with progressive mental, behavioral and functional
decline. Brain regions involved in the progression of AD include
the entorhinal cortex and the hippocampus and correlate with
these cognitive changes (Delacourte et al., 1999; Sarazin et al.,
2007). Episodic memory is one of the first cognitive functions
impaired (Welsh et al., 1991) and remains predominant in the
course of the disease and is therefore a core feature for diagnosis.
Several studies have also illustrated decreased olfactory function
with increasing age symptomatically resulting in difficulty to
differentiate odors which can be predictive of broader cognitive
deficits such as AD (Doty et al., 1984; Wilson et al., 2009). The
involvement of the olfactory system in the initial presentation
of AD is a result of damage to central olfactory areas such
as the entorhinal cortex and the hippocampus in the early
stages of disease (Price et al., 1991; Wilson et al., 2007). As
olfactory deficits can appear even prior to clinical symptoms
of AD (Masurkar and Devanand, 2014) it has been suggested
that testing the olfactory system with respect to accelerated
neurodegeneration may offer a unique insight for early detection
of cognitive decline (Franks et al., 2015).
Accompanying the widely seen cognitive deficits of AD there
is a wide range of non-cognitive behavioral symptoms associated
with disease such as anxiety, depression and sleep disturbances
(Mega et al., 1996; Musiek et al., 2015). Symptoms of depression
can precede the onset of AD (Devanand et al., 1996) and
patients with prior diagnosis of depression are more likely to
have recurrence during the course of the AD (Strauss and
Ogrocki, 1996). Sleep disturbances are common in AD patients
with increased wakefulness during the night and increased time
spent sleeping during the day. This behavior has been proposed
to have important implications on cognition (Hatfield et al.,
2004).
Over the last 20 years, many groups have developed drugs in
accord with the amyloid cascade hypothesis that target the APP
and Aβ peptides. However, this strategy has not been successful.
It has been proposed that the deposits of Aβ do not correlate with
cognitive impairments and that Aβ deposition can also be found
in cognitively normal individuals (Golde et al., 2011;Morris et al.,
2014) Some studies have suggested that age is the most accepted
risk factor of AD and that age should be the central argument
in any hypothesis (Herrup, 2015). Further, other groups have
suggested that sAD has not been targeted early enough (Selkoe,
2011).
The “mitochondrial cascade hypothesis,” on the other hand,
promotes the idea that the development of sAD is due to age-
related mitochondrial energy deficits, increased reactive oxygen
species (ROS) production and oxidative stress. The result of these
alterations may lead to Aβ accumulation, neuronal death, and
dementia (Swerdlow et al., 2010). Indeed, mitochondria-derived
ROS themselves can trigger Aβ generation by enhancing the
amyloidogenic pathway (Leuner et al., 2012).
It has been suggested that decline of cognitive function in
the aging brain can be due to the cumulative presence of
ROS. ROS that include superoxide anions, hydrogen peroxide,
hydroxyl radicals and hydroxyl anions are highly reactive free
radical derivatives of oxygen species that occur as a natural
by-product of cellular metabolism, most notably mitochondrial
respiration (Milton and Sweeney, 2012). High ROS levels cause
oxidative stress that may result in cell death, ultimately leading to
neurodegenerative diseases including AD (Lin and Beal, 2006).
This link has previously been demonstrated between oxidative
damage in the hippocampus of rats and learning impairment
(Nicolle et al., 2001). Fus1, a tumor suppressor protein residing
in mitochondria, maintains mitochondrial homeostasis and is
highly expressed in the brain (Ivanova et al., 2007). Fus1 is
involved in regulation of inflammatory and stress responses
to various stimuli, infection agents and tumor growth (Hood
et al., 2013; Yazlovitskaya et al., 2013, 2015). Fus1 deficient
mice display signs of chronic inflammation including increased
cytokine production, NF-κB activation and increased levels of
ROS (Uzhachenko et al., 2012, 2014). Inflammation leading to
ROS production, one of the causative factors of aging, has been
shown to reduce expression of Fus1. This reduction however,
can be rescued using ROS scavengers demonstrating a ROS-
dependent regulation of Fus1 (Ivanova et al., 2009). Therefore,
a constant overproduction of ROS due to the aging process
may reduce Fus1 expression leading to a state of chronic
inflammation (Uzhachenko et al., 2012). In turn, reduced Fus1
expression results in perturbation of mitochondrial homeostasis,
exacerbation of ROS production, chronic oxidative stress, which
can ultimately lead to sAD as suggested by the “mitochondrial
cascade hypothesis’ (Swerdlow and Khan, 2004). Thus, Fus1
knockout mouse model may represent a novel model for the
study of sAD.
The use of preclinical animal models has been invaluable
in the study of AD whereby neuropathological changes,
characterized by progressive cognitive decline, ultimately involve
multiple cognitive, neuropsychological and behavioral domains.
In order to know if the Fus1 knockout female mice display the
behavioral and biochemical alterations characteristic for sAD
at early stages, we implemented a battery of behavioral tests
comparing KO mice with the age- gender- and strain- matched
WT mice. We used 4–5 months old mice, the age in which the
control mice are considered mature adults but not yet affected
by senescence (86% survival at age of 500 days, Anisimov et al.,
2015).
Deficits in olfaction can be used as an early indicator of
underlying dysfunction and utilizing odor paired-associated
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tasks are analogous to verbal paired-associated tasks in humans
(Bunsey and Eichenbaum, 1996). Here, the habituation/cross-
habituation task, which relies upon the animal’s tendency to
investigate novel odors, tests if the animal can differentiate
between the sequential presentation of different odors (Yang and
Crawley, 2009). The Morris water maze and passive avoidance
tasks are an excellent representation of both learning and
memory. Morris water maze is a widely used paradigm to
investigate spatial reference learning and memory determined by
the animal’s ability to learn the location of a hidden platform
(Morris, 1984). Meanwhile in the passive avoidance task the
animal must refrain from entering a chamber paired with an
aversive stimulus, in this case a foot shock, to test associative
learning and memory (Hall, 1934; van der Poel, 1967). One final
area of investigation included the psychological disturbances
associated with aging and AD. These include circadian rhythm
disturbances alongside fear and anxiety. The anxiety of the
animal model was determined using the open field and the
light/dark box to determine freezing, defecation and thigmotaxis
(Hall, 1934). Anhedonia, which is the loss of sensitivity to
reward and related to depression, was determined by the sucrose
preference test (Romano et al., 2015). In light of recently
published concerns about reproducibility of animal research
(Pusztai et al., 2013; Jilka, 2016) we adopted Noldus video-
tracking for all the behavioral assays reported herein. This
methodology avoids experimenter bias and increases accuracy of
the collected data.
EXPERIMENTAL PROCEDURES
Subjects
In this study we compared the behavior of young female Fus1
KO/129sv mice and Fus1 WT/129sv generated by Dr. Alla
Ivanova (Ivanova et al., 2007). We used 5 months old Fus1 KO
(n = 23) and WT mice (n = 14) for the experiments. The
vivarium had a 12-h/12-h inverted light cycle with lights off at
10:30 am. All animals were housed individually in polycarbonate
cages (12 × 12 × 25 cm) with controlled humidity (40%) and
temperature (22◦C), and the mice were fed ad libitum chow
(Harlan 18% protein rodent diet). All the animals were treated
according to the guidelines established by the U.S. National
Institutes of Health (National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, 2011). The experimental protocols were approved by
the Institutional Animal Care and Use Committee of the John
B. Pierce Laboratory. The John B. Pierce Laboratory is AAALAC
accredited. Animals were tested as shown in Figure 1.
Habituation/Cross-Habituation Test
(HaXha)
This olfactory-dependent behavioral task was performed in a
sealed semi-transparent white acrylic box (26 × 38 × 16 cm)
in which a cotton-tipped wood applicator (4 cm long, Puritan
REF 806-WC) was presented 1 cm from the bottom of the box
and placed on the center, while retained by a 54 × 54 × 4mm
applicator holder. We presented one of the 3 odorants to the
applicator: mineral oil (MO, control), amyl acetate (AA) (diluted
1% in MO), phenyl ethanol (PE) (1% in MO), and the social odor
(S) (obtained by swabbing the cage of non-experimental CRE-
OMP female mice). A total of 12 trials were tested per mouse,
where each odorant was presented three times in succession per
session to yield the following order: MO1-3, AA1-3, PE1-3, and
S1-3. Each trial consisted of 2 min per odorant exposure and
inter-trial of 1min between stimuli. The time spent smelling
the cotton tip was registered using a USB camera (Logitech
HD Pro C920, 1920 × 1080 pixels) mounted at the ceiling
of the box, and used the Noldus behavioral tracking system
(EthoVision XT, version 10.1, Noldus Information Technology
b.v., Wageningen, The Netherlands) to identify and score the
behavior of the animal. Smelling was defined as being oriented
toward the applicator tip while the nose is within 2 cm of it. This
test evaluates if mice are able to spontaneously recognize a novel
odorant stimulus by spending more time smelling the applicator
(cross-habituation phase, trial 3 vs. new odor 1), as opposed to
the time that the mice spent on each stimulus (habituation phase,
trial 1 vs. 3 of same odor).
Short Term and Long Term Olfactory
Memory (STOM, LTOM)
These behavioral tasks were performed in the same box of
the habituation/cross-habituation (HaXha) test, recorded with
same camera (Logitech HD Pro C920, 1920 × 1080 pixels).
We used Noldus as the software to track the behavior of mice
and following the same approach as HaXha. A social odor
was used in both behaviors: female urine (obtained from 3
mice and diluted 1% in deionized water) for the short term
olfactory memory (STOM), and dam urine (obtained from
3 female dams, 1% in deionized water) for the long term
olfactorymemory (LTOM). For the STOM, we presented a cotton
applicator with female urine (1%) for 20 s after 1 min (3X),
2, 4, 8, and 16 min inter-trial-intervals (ITIs), after exposure
of an applicator with only water as a control stimulus on
each trial. Therefore, we ensured that the behavioral response
across trials was not due to the applicator-diluent presentation,
but due to the odorant. We tested LTOM using dam urine
(1%) as stimulus for 2 min at 10 min (2X), 30, 60, 120,
240 min to 24 h ITIs, each also preceded by water control
presentations.
Sucrose Preference Test (SPT)
Our sucrose preference test was based on Romano et al. (2015).
The mice were placed in regular home cages (22.5 × 16.7 ×
14 cm) and had access to two drinking tubes, one filled with 20
ml tap water, and the other with 20 ml 10% sucrose (Sucrose,
S5016, Sigma-Aldrich) diluted in tap water. The location was
randomized. During the next 48 h, free consumption of water
and 10% sucrose solution took place in the presence of ad libitum
food. Fluid intake was measured at 24 h intervals. Sucrose
preference was calculated from the amount of sucrose solution
consumed, expressed as a percentage of the total amount of liquid
drunk at each 24-h interval.
Open Field Test (OFT)
The Open Field was based on Chen et al. (2013) and Galeano
et al. (2014), and was used to assess spontaneous exploratory
activity and anxiety-related behaviors (Hall, 1934). Anxiety and
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FIGURE 1 | Diagram representing the order of the behavioral tasks, the number of experimental days and the number of WT and Fus1 KO mice tested.
exploratory activities were evaluated by allowing mice to freely
explore an open field arena for 15min. The testing apparatus was
a classic open field (i.e., a white PVC square arena, 50 × 50 cm,
with walls 40 cm high). A video camera (Logitech HD Pro C920,
1920 × 1080 pixels) connected to a Noldus computer system
was placed above the box. Each mouse was placed individually
on the center of the arena and the performance was monitored
by the video tracking system (Noldus System). The central area
was arbitrarily defined as a square of 35 × 35 cm (half the total
area). The ethological measures analyzed included frequency and
duration spent at each area (center and periphery) and locomotor
activity.
Dark-Light Box Test (DLBT)
This task is used to detect activity in disorders related to
generalized anxiety and used to complement the OFT (Ramos,
2008). The task is based on the innate aversion of rodents to
brightly illuminated areas and on the spontaneous exploratory
behavior in response to a novel environment and light (Crawley
and Goodwin, 1980; Bourin and Hascoët, 2003). This task
was based on Van Dam et al. (2003) and Pinton et al.
(2011).
The apparatus consisted of a dual compartment box with free
access between them. The dark compartment consisted of gray
PVC and had a roof on the top. The other box was exposed and
was brightly illuminated by room light. Each animal was placed
at the center of the illuminated compartment, facing the central
opening to the dark compartment and the time spent in the light
compartment was recorded during 5 min. Anxiogenic activity
was evaluated by the time spent in the illuminated compartment
and the latency for the first light-dark transition.
Hidden Cookie Test (HCT)
This test measures the latency of the mice to find a hidden
cookie in one of the corners of the home cage. The mice were
familiarized with the chocolate cookie for a week before the test.
A quarter of chocolate cookie (∼2.5 g) was placed every 48 h
for three times in the home cage on the top of the bedding.
Mice received food and water ad libitum. After a week of the
familiarization phase, mice were deprived of the cookie for 3 days
before the test. On the first day of the test, mice were individually
caged with 1 cm of clean bedding. Initially, a piece of cookie was
hidden in one corner of the cage and the latency to finding the
cookie was recorded and analyzed by Noldus. An hour and a half
later, another piece of cookie was placed in the same corner as
the first trial, and the behavior was tracked and analyzed. At the
end of the second trial, the mice were taken to the animal room.
The next day, mice were placed in the experimental cages and the
piece of cookie was hidden in a corner different from the last day,
and this was tested twice following the same protocol as the first
experimental day.
Morris Water Maze Test (MWMT)
Spatial reference learning and memory were evaluated in a water
maze adapted from that previously described by Morris (1984)
and was based on Van Dam et al. (2003), Javed et al. (2011), Chen
et al. (2013) and Galeano et al. (2014).
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The test was performed in a circular galvanized steel pool of
90 cm in diameter and 40 cm height, filled with 20 cm of water
tainted with a non-toxic white paint (acrylic paint, 20503 white,
Apple Barrel). As it is known that the standard Morris water
maze can interfere with physiology, likely due to the stress of heat
loss (Iivonen et al., 2003), we opted to refine this method to be
less stressful by not maintaining it at room temperature (21 ±
2◦C), but instead between room and central body temperature
(37◦C), i.e., at 29 ± 2◦C. The pool was virtually divided into
four equal quadrants, labeled north–south–east–west. A camera
connected to a Noldus video tracking system was mounted above
the maze.
During training, a platform (10 cm in diameter and made
of transparent acrylic plastic) was submerged 1 cm below water
surface and was placed at a fixed location in one of the quadrants.
If the mice were not able to reach the platform within 120 s,
they were guided to the platform where they had to stay for
30 s before being returned to their home cage for 30 s. All
mice were given four trials per day, once from each quadrant,
for 4 consecutive days. The starting position was randomized
among four quadrants of the pool. During training trials, the
latency to reach the escape platform and the path length were
measured.
A probe trial was performed 24 h after the last day of training.
During the probe trial, mice were allowed to swim in the pool
without the escape platform for 120 s. The latency to reach the
platform (s), swim distance (cm), and swim speed (cm/s) were
recorded using an automated tracking system (Noldus). During
the probe trial, performance was expressed as the percentage of
time spent in each quadrant of the MWM, and the number of
crossings through the position where the platform used to be
during acquisition (using 15 cm diameter).
Nestlet Building Task (NBT)
After a 24 h rest period, mice were housed individually and
tested for nest building (adapted from Deacon, 2006; Wesson
and Wilson, 2011). Two hours prior to the onset of the dark
phase of the lighting cycle, individual cages were supplied a
commercially available Nestlet pressed cotton square (Ancare,
UK agent, Lillico). The next morning (∼16 h later) cages were
inspected for nest construction. Pictures were taken prior to
evaluation for documentation. Nestlet nest construction was
scored blind to genotype using the system of Deacon (please
see Deacon, 2006, for detailed scoring standard). Briefly, in this
5 point scale, 1 indicates a >90% intact nestlet, whereas a 5
indicates a nestlet torn >90% and a clear nest crater.
Sleep/Awake Task
Piezo foil PVDF based circadian rhythm scoring of sleep/wake
rhythm was used as established in Donohue et al. (2008), and
further used in AD studies (Duncan et al., 2012; Mang et al.,
2014; Sethi et al., 2015). Mice were individually housed for 5
days in clean plastic cages (Signal Solutions LLC) with ∼5mm
of corn cob bedding lining the floor and lined with the PVDF
foil. Activity was recorded for the full duration and analyzed for
circadian rhythm of locomotion, REM and NREM sleep.
Data Analysis
Statistical analysis was conducted by GraphPad v6.07. Results
were expressed as mean ± standard error (SEM). Repeated
measures one-way ANOVA was used for comparison of the same
group in the HaXha test (main effect: MO, AA, PE, S; dependent
variable: exploration time); as well as the STOM and LTOM
tasks (main effect: urine stimuli; dependent variable: exploration
time). Two-way ANOVA for SPT [main effects: % preference/mL
consumed and groups (WT vs. Fus1 KO)]. For PAT was used
a two-way ANOVA (main effects: latency and groups). Two-
way ANOVA for OFT (main effects: center/periphery areas and
groups; dependent variable: distance traveled, activity, number
of fecal boli, zone preference). Repeated measures one-way
ANOVA was used for HKT (main effect: cookie stimulus;
dependent variable: latency to find the cookie). One-way RM
ANOVA for the MWMT (main effect: platform; dependent
variable: latency, velocity, distance traveled). All the analyses were
followed by Bonferroni-corrected post-hoc tests. The rest of the
behavioral tests were analyzed using paired and unpaired one-
tailed Student’s t-test. Statistically significant differences were
accepted at P < 0.05.
To allow for RM ANOVA of behavioral tests with repeated
measures we replaced the following missing values with dummy
values based on the average for the relevant group and trial: 3
values from the short term memory WT group; 2 values in the
swimming velocity MWM (training sessions of the test) for the
WT; 1 value in the swimming velocity MWM (training session of
the test) for the Fus1 KO; 2 values on the distance traveledMWM
(training session of the test) for the WT; 1 value on the distance
traveled MWM (training session of the test) for the Fus1 KO.
Western Immunoblot Analysis
Protein lysates were prepared from olfactory bulbs and
hippocampi of 5 months old WT and KO female mice using
RIPA buffer with protease inhibitors followed by sonication by
ultrasound and clearing via centrifugation at maximum speed
using Eppendorf tabletop centrifuge. Protein concentration
was quantified using BCA reagent (Thermo Fisher Scientific,
Rockford, IL). Protein extracts (40 µg/well) were subjected to
Western immunoblot analysis. We used antibodies against the
following proteins: PRDX1 (Sigma), ACC1, pACC1, AMPKα,
pAMPKα, NGFR, TrkB, Bcl-xL, Rack1 (all from Cell Signaling
Technology), Calretinin (Millipore), LC3 (Abcam). The band
intensity was determined using ImageJ software, normalized to
loading control (β-actin). The data are presented as a relative
intensity of WT bands over KO bands. Phospho-index was
determined as a ratio of phosphorylated/total protein intensities.
RESULTS
Young Female Fus1 KO Did Not Show Early
Olfactory Impairments in the Habituation
Task
Initial experiments using Haxha task established if the young
Fus1 KO mice (5 months) showed early signs of olfactory
dysfunction when compared to WT animals by evaluating their
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ability to discriminate between a sequentially presented set
of odors. The stimuli used were selected for the following
reasons. Mineral oil (MO) was the odorless diluent of the two
monomolecular odors and used as a control stimulus, to assess
baseline exploration and habituation. Phenyl ethanol (PE) is a
non-trigeminal rose-like odorant allowing to selectively probe
the olfactory system. Amyl acetate (AA) is an often used banana-
like food odorant. Last, we used social odor (SO), as prior
work had shown this stimulus to evoke longer exploration times
(Coronas-Sámano et al., 2014), thereby enhancing the sensitivity
of the test. There was an overall effect on exploration time
across the odors [F(2.95, 62.02) = 11.68, P < 0.001; one-way RM
ANOVA, N = 22, Figure 2] in the Fus1 KO mice. Firstly, the
animals displayed habituation between the repeated presentation
of the same odors; MO1 (3.9 ± 0.9 s) and MO3 (1.5 ± 0.6 s;
P = 0.02), PE1 (2.3 ± 0.7 s) and PE3 (0.3 ± 0.2 s; P = 0.03),
and for social odor S1 (12 ± 2.2 s) and S3 (1.9 ± 0.7 s; P =
0.0007). Secondly, the KO animals displayed cross-habituation
between the presentation of different odors; AA3 (0.2 ± 0.1 s)
and PE1 (2.3 ± 0.7 s; P = 0.02) and PE3 (0.3 ± 0.2 s) vs.
S1 (12 ± 2.2 s; P = 0.0001). The WT group also showed an
effect on the exploration time across stimuli [F(2.31, 30.02) = 5.8,
P = 0.005, N = 14, Figure 2]. However, these animals only
cross-habituated between PE3 (0.2 ± 0.1 s) and S1 (14.7 ±
2.6 s; P = 0.0005). We did not find statistical differences in the
exploration time between both groups [F(1, 405) = 1.22, P =
0.27, two-way ANOVA), nor a significant interaction between
both groups and the odor exposures [F(11, 405) = 0.5, P = 0.89,
two-way ANOVA]. We conclude that Fus1 KO mice do not
have impaired odor sensitivity (cross-habituation did not differ
between groups) or short term odormemory deficits (habituation
did not differ between groups).
WT Mice Habituated Sooner than the Fus1
KO Mice in the Short Term Olfactory
Memory Task
Following the basic concept of the HaXha task, but at longer
inter-stimulus intervals, we tested the short term olfactory
memory in the KO mice. Female urine was used as the stimulus,
and the time that each mouse spent with its nose within 2 cm of
the cotton applicator, a reasonably accurate estimate of sniffing-
mediated odor exploration (Coronas-Samano et al., 2016), was
recorded (described in Experimental Procedures).
The WT group exploration time was 1.7 ± 0.5 s during the
initial exposure of urine and 0.8 ± 0.3 s during the last exposure,
trending to reduce their exploration time during the consecutive
exposures (R2 = 0.28, P = 0.0003, slope −0.22 s/trial; linear
Pearson correlation was used throughout this paper to determine
trends). In fact, the WT showed a statistical difference in the
exploration time of the urine soaked cotton tip [F(2.34, 30.45) =
5.06, P= 0.009, one-way RMANOVA,N = 14, Figure 3A, line in
blue]. The WT mice habituated to the urine odor from the third
exposure, showing statistical differences from the initial exposure
1.7 ± 0.5 s compared with 1 min ITI (third exposure; 0.2 ± 0.1 s,
P = 0.03), similarly after 2min ITI (0.3 ± 0.2 s, P = 0.03), after
4min ITI (sixth exposure; 0.3 ± 0.2 s, P = 0.02), after 8 min
FIGURE 2 | Habituation/cross-habituation task. Data depicts mean ±
SEM for the time (sec) spent by mice WT (blue; n = 14) and Fus1 KO (red; n =
22), sniffing within 2 cm of a presented cotton tip with one of the following
odors: mineral oil (MO, control), amyl acetate (AA, 1%), phenyl ethanol (PE,
1%), and the social odor (S) (obtained by swabbing the cage of a female
mouse. Each odorant was presented three times in succession for 2 min with
an inter-trial-interval of 1 min to yield the following order: MO1-3, AA1-3,
PE1-3, and S1-3. Significant habituation of the animals to the repeated
presentation of an odor is represented as (•) and cross-habituation of an
animal to the presentation of an alternate odor is represented as ().
Habituation was determined at significance difference in time between the first
and last presentation of the same odor. Cross-habituation was determined as
the significant difference between the last presentation of an odor and the first
presentation of an alternate odor. Statistical analysis performed was one-way
RM ANOVA with repeated measures followed by Bonferroni’s post-hoc
analysis; ,•P < 0.05, ,••• P < 0.001. The Fus1 KO were able to
habituate to MO, PE, and S, and cross-habituate for PE and S. The WT mice
were able to cross-habituate for S.
ITI (seventh exposure; 0.01 ± 0.01 s, P = 0.03). The WT mice
did not show statistical differences in the fourth exposure (0.5 ±
0.4 s, P = 0.95) nor the last exposure (0.8 ± 0.3 s, P = 0.69). The
WT group did not show any effect in the exploration time across
the trials [F(2.48, 32.23) = 1.86, P = 0.16, one-way RM ANOVA,
N = 14, Figure 3A, line in black) when investigating the water
control. In fact, they explored 0.4 ± 0.2 s in the initial trial and
0.9 ± 0.4 s during the last trial, with no trend over trials (R2 =
0.13, P = 0.55). Comparisons between the exploration time of
the presented cotton tips with water or urine stimuli illustrated a
difference between responses [F(7, 197) = 2.78, P = 0.009; two-
way ANOVA, Figure 3A]. This was evident by the increase in
exploration time observed between the second exposure (after 1
min ITI) of water (0.7± 0.4 s) vs. urine (2.4± 0.7 s; P = 0.005).
Fus1 KO mice also showed changes in exploration time with
repeated urine exposures [F(1.78, 39.1) = 4.59, P = 0.01 one-way
RM ANOVA, N = 23, Figure 3B, line in red]. The KO mice
habituated on the second trial. The above was evident when
comparing the time spent exploring the initial exposure (2.6 ±
0.6 s) with the 1min ITI (second trial; 0.8 ± 0.4 s, P = 0.001),
1min ITI (fourth trial; 0.3 ± 0.1 s, P = 0.006), 2min ITI (fifth
trial; 0.3 ± 0.1 s, P = 0.005), 4min ITI (sixth trial; 0.13 ± 0.09 s,
P= 0.002), 8 min ITI (seventh trial; 0.7± 0.2 s, P= 0.04), 16min
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FIGURE 3 | Short term olfactory memory. (A) Graphical representation of the time (sec) spent by WT mice (n = 14) sniffing within 2 cm of a cotton tip presenting
either water (black) or urine (blue) collected from a non-experimental female. Inter-trial-intervals (ITIs) were as follows: 1, 1, 1, 2, 4, 8, 16 min. Habituation (*) to the odor
was determined by a significant reduction in exploration time when compared to the trial with the highest exploration time (one-way RM ANOVA followed by
Bonferroni’s post-hoc, P < 0.05). (ϕ) denotes significance between the exploration time of the urine and the water control two-way ANOVA followed by Bonferroni’s
post-hoc, *ϕP < 0.05. No significant difference was observed between the initial and last trial for the water control. (B) Data illustrates time (sec) spent by Fus1 KO
mice (n = 23) sniffing within 2 cm of a cotton tip presenting either water (black) or urine (red) collected from a non-experimental female. Habituation determined by a
significant reduction in exploration time when compared to the trial with the highest exploration time; one-way RM ANOVA followed by Bonferroni’s post-hoc, *ϕP <
0.05 was seen by the fourth trial (*). Significant difference between exploration time of the urine and the water control is shown in the initial trial (ϕ) two-way ANOVA
followed by Bonferroni’s post-hoc, *ϕP < 0.05. No significant difference was observed between the initial and last trial for the water control. (C) Comparison illustrating
the exploration time of the WT (blue; n = 14) and Fus1 KO (red; n = 23) within 2 cm of a cotton tip presenting urine. Significant difference between groups is denoted
as (ϕ) two way ANOVA followed by Bonferroni’s post-hoc, ϕP < 0.05. (D) Comparison illustrating the exploration time of the WT (blue; n = 14) and Fus1 KO (red; n =
23) within 2 cm of a cotton tip presenting water. No statistical differences between groups was observed.
ITI (eight trial; 0.4 ± 0.2 s, P = 0.004). The Fus1 showed “cross
habituation” (i.e., reversal of habituation to the same stimulus)
by the third exposure which did not show a statistical difference
to the initial odor exploration time (1min ITI; 2.3 ± 0.4, P >
0.99). In comparison, these animals did not show a significant
change in exploration time when presented with cotton soaked
with water [F(2.38, 52.39) = 0.62, P = 0.57, one-way RM ANOVA,
N = 23, Figure 3B, line in black], showing lower responses of
0.7 ± 0.2 s on the initial exposure to 0.9 ± 0.6 s on the last trial
with no trend across trials (R2 = 0.02, P = 0.81). Further, the
comparisons between the cotton presentation of water or urine
stimuli demonstrate significant [F(7, 308) = 3.23, P = 0.003, two-
way ANOVA, N = 23, Figure 3B] differences between the initial
exposure of water (0.7± 0.2 s) vs. urine (2.6± 0.6 s) (P = 0.03) a
difference also seen in the third exposure to water 0.5 ± 0.2 s vs.
urine 2.3± 1.2 s (P = 0.04).
The WT and Fus1 KO groups did not show differences in
urine exploration [F(1, 278) = 0.43, P = 0.51; two-way ANOVA,
Figure 3C]. Nevertheless, the interaction between groups and
exposures was significant [F(7, 278) = 2.32, P = 0.02; two-way
ANOVA Figure 3C], reflecting their different temporal profiles.
Fus1 KO showed higher exploration time during the third
exposure (after 1 min ITI) 2.3 ± 1.2 s to the stimulus compared
with 0.17 ± 0.1 s from the WT (P = 0.02). Finally, there was no
difference between the WT and Fus1 KO groups related to the
amount of time spend exploring the cotton tip with the water
stimulus [F(1, 279) = 0.3, P= 0.58; two-way ANOVA, Figure 3D],
nor the interaction effect between groups throughout the trials
[F(7, 279) = 0.26, P = 0.97; two-way ANOVA]. The relatively late
habituation by Fus1 KO mice may indicate a mild impairment of
short-term odor memory in the Fus1 KO mice.
Fus1 KO Mice Did Not Habituate in the
Long Term Olfactory Memory Task
The aim of this behavioral task was to elucidate whether the
animals were able to habituate to repeated presentations of
the same stimulus (dam urine, in contrast to non-pregnant
female urine in the STM) over minutes to hours. The WT
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group showed statistical differences in the effect of exploration
time observed in response to the urine stimulus over repeated
exposures [F(1.19, 15.52) = 5.31, P = 0.03; one-way RM ANOVA,
N = 14, Figure 4A, blue line], although we did not find statistical
differences comparing the initial exposure to the subsequent
seven exposures over time post-hoc. However, the WT group
reduced their urine exploration time from 6.8± 2.5 s at the initial
exposure to 0.5 ± 0.3 s after 24 h ITI (R2 = 0.29, P = 0.001
slope −0.49 s/trial). A planned comparison between the initial
and the second exposures (after 10 min ITI) was significant (one-
tailed paired t-test P = 0.02), suggesting that the WT were able
to habituate to the urine after a long inter trial period, even at the
end of the task 24 h later (one-tailed paired t-test P= 0.02). As we
expected from the STM task, the cotton soaked with only water
(the control stimulus) did not represent a stimulus of interest for
the WT group, since they did not show any trend in exploration
time, from the initial exposure to the cotton tip (1.5 ± 0.7 s)
to the exposure 24 h later ITI [0.9 ± 0.3 s; R2 = 0.058, P =
0.7; F(2.96, 38.52) = 0.81, P = 0.5, one-way RM ANOVA, N = 14,
Figure 4A, black line]. In addition, WT mice showed significant
differences in exploration time on the initial presentation of urine
(6.8± 2.5 s vs. water 1.5± 0.7 s; P < 0.0001, Figure 4A).
The Fus1 KO mice did not show any changes in exploration
time for the urine stimulus [F(2.89, 60.73) = 0.37, P = 0.76, N =
22, Figure 4B, red line]. They did not tend to reduce their
exploration time across trials (R2 = 0.02, P = 0.73), and a
planned comparison did not reveal a difference in exploration
time between the initial trial (3.4± 0.6 s) and the second exposure
(2.8 ± 1.2 s; one-tailed paired Student’s t-test P = 0.15), or even
24 h later (2.4 ± 0.71 s; one-tailed paired Student’s t-test P =
0.15), suggesting that they did not habituate to the urine stimuli.
This was tentatively substantiated by the finding that the Fus1
KOmice did explore the urine (3.4± 0.58 s) more than the water
control (0.95± 0.27; P < 0.001, planned paired one-tailed t-test).
Also, they did not show changes in the exploration time for the
control stimulus (cotton tip with water) over time [F(3.77, 79.23) =
1.18, P = 0.33; one-way ordinary RM ANOVA, Figure 4B, black
line] and they did not show a trend across trials from the initial
exposure (1.0 ± 0.3 s) to the last (0.8 ± 0.3 s; R2 = 0.05,
P = 0.88). Further, the Fus1 did not show statistical differences
between the exploration time of the control and dam’s urine
stimuli [F(7, 294) = 0.99, P = 0.43].
We did not find any differences between the WT and Fus1
KO groups exploration time in response to the urine stimulus
FIGURE 4 | Long term olfactory memory. (A) Illustration of the time (sec) spent by WT mice (n = 14) sniffing within 2 cm of a cotton tip presenting either water
(black) or urine (blue) collected from a non-experimental dam female. Inter-trial-intervals (ITIs) were as follows: 10, 10, 30min, 1, 2, 4, 24 h. A planned comparison was
carried out to know if the exploration time decreased after the initial stimulus of urine. The WT group decreased their time smelling the urine from the initial to the
second exposures, also at the end of the task 24 h later (paired one-tailed Student’s t-test, *P < 0.01) Further, there was a significant difference in the exploration time
at the initial trial between urine and water (two-way ANOVA followed by Bonferroni’s post-hoc, ϕP < 0.001). (B) Data illustrates time (sec) spent by Fus1 KO mice (n =
22) sniffing within 2 cm of a cotton tip presenting either water (black) or urine (red) collected from a non-experimental dam female. No significant differences were
observed between exploration time of the urine and the water control or between the initial and later trials. For the initial trial Fus1 KO mice explored the urine more
than the water control (*P < 0.0001, planned one-tailed paired t-test). (C) Comparison illustrating the exploration time of the WT (blue; n = 14) and Fus1 KO (red; n =
22) within 2 cm of a cotton tip presenting urine. No significant difference between groups was observed. (D) Comparison illustrating the exploration time of the WT
(blue; n = 14) and Fus1 KO (red; n = 22) within 2 cm of a cotton tip presenting water. No statistical differences between groups was observed.
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FIGURE 5 | Sucrose preference task. (A) Percentage preference dot plot representing individual animal consumption of sucrose (10%) in water when compared to
the water control. Sucrose consumption is expressed as a percentage of overall consumption of both sucrose and control for the WT (n = 14; blue) and Fus1 KO (n =
22; red) mice over two experimental days. Data is averaged for all animals for overall preference of mean ± SEM. No difference in the total sucrose preference was
observed between both groups. (B) Dot plot representing the overall individual animal consumption (mL) of sucrose (10%) in water and the water control for the WT
(n = 14; blue) and Fus1 KO (n = 22; red) mice over two experimental days. Data is averaged for all animals for liquid consumption (mean ± SEM). No statistical
difference in liquid consumption was observed between groups.
[F(1, 272) = 2.67, P = 0.1; two-way ANOVA, Figure 4C), nor
a significant interaction between groups and trials [F(7, 272) =
1.2, P = 0.29; two-way ANOVA]. The groups did not show any
differences in exploration time for the water control [F(1, 272)
= 1.16, P = 0.2; two-way ANOVA, Figure 4D], nor significant
interaction between groups and exposures [F(7, 272) = 1.14,
P = 0.34; two-way ANOVA]. Overall, the lack of habituation of
the Fus1 KO mice may suggest they have mold long term odor
memory impairments.
Young Fus1 KO Female Mice Do Not Show
Anhedonia
On the first day of the test both groups showed high sucrose
preference expressed as the percentage sucrose ingested over the
total amount ingested: WT 96.6 ± 1.5% and Fus1 KO 84.1 ±
5.2%. This preference was maintained during the second day of
the test, in which WT consumption was 90.9± 2.9% and the KO
87.2± 5.1% with no statistical difference between groups [F(1, 68)
= 2.55, P = 0.12; two-way ANOVA, WT N = 14, Fus1 KO N =
22, Figure 5A].
Also the total amount of water and 10% sucrose consumedwas
measured for every day of the test. Over the first day, theWTmice
consumed 7.9± 0.9 mL and the Fus1 KO 7.3± 0.8 mL. Similarly,
on the second day, the WT consumed 8.3 ± 1.1mL and the KO
8.0± 0.9 mL with no differences between groups [F(1, 68) = 0.02,
P = 0.87; two-way ANOVA, Figure 5B]. We conclude that Fus1
KO mice did not show anhedonia, a measure of depression.
Fus1 KO Mice Have No Locomotor or
Anxiety Alterations in the Open Field Test
This test evaluates the locomotor function of mice by collecting
data regarding their velocity, total distance traveled, number of
fecal boli as a sign of emotional stress (Hall, 1934; Archer, 1973),
level of anxiety (total time in the periphery-center areas) and
locomotor activity (active or inactive) of every mouse.
The arena field was divided in two areas, center and periphery,
by configuring the Noldus behavioral tracking. The total time
in which every animal spent in each area was measured. The
WT and Fus1 KO mice showed statistical differences in the total
time spent exploring each arena zone [F(1, 68) = 1133, P < 0.001;
two-way ANOVA, WT = 14, Fus1 = 22, Figure 6A], however,
both groups spent more time in the periphery (WT = 846 ± 20
s; Fus1 KO = 808 ± 22 s) rather than on the center of the cage
(WT= 53± 20 s; Fus1 KO= 92± 22 s; P < 0.001).
Further, the percentage of time in which animals were active
vs. inactive was determined. Both WT and KO mice showed
statistical difference between their activity and inactivity periods
[F(1, 68) = 306.3, P ≤ 0.001; two-way ANOVA, Figure 6B]. The
WT and the Fus1 KO showed a higher percentage of activity
compared to inactivity (WT 82.3 ± 2.9% active, 17.8 ± 2.9%
inactive, P < 0.001; Fus1 KO 74.9 ± 3.2 active, 25 ± 3.2%
inactive, P < 0.0001) and there were no differences between
groups relating to percentage of activity (P = 0.7).
We measured velocity and the total distance traveled of
every mouse during the test to establish whether any potential
differences between the groups on the main test outcome could
be explained thereby and also to establish if any were motorically
impaired. The velocity of the WT during the task was 3.3 ±
0.4 cm/s, while the Fus1 KO obtained 3.2 ± 0.3 cm/s, not
showing statistical differences (one-tailed unpaired Student’s t-
test, P = 0.36, Figure 6C). The WT traveled 3000 ± 316 cm
and the Fus1 KO 2813 ± 288 cm with no statistical differences
between groups (one-tailed unpaired Student’s t-test P = 0.34,
Figure 6D).
In addition, the total number of fecal boli was counted
at the end of every trial and compared between groups. The
defecation in rodents has been considered a reliable index of
emotionality and reflects the level of activation of its sympathetic
nervous system when they respond to a different stress situations
(Seliger, 1978). No differences were observed in the total fecal
boli counts (WT 6 ± 1 boli; Fus1 KO 5 ± 0.4 boli, one-
tailed unpaired Student’s t-test, P = 0.17, Figure 6E). These
data suggest that Fus1 KO mice did not show increased anxiety
over WT.
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FIGURE 6 | The open field test. (A) Bar chart illustrating the total exploration time (sec; mean ± SEM) of WT (blue; n = 14) and Fus1 KO (red; n = 20) animals in
either the center or the periphery of the experimental box. Significance determined by two way ANOVA followed by Bonferroni’s post-hoc, ***P < 0.001. (B)
Percentage dot plot of activity of WT (blue; n = 14) and KO (red; n = 20) over the duration of the task (15 min). Average activity and inactivity were determined as a
percentage of total movement (mean ± SEM). Significance was obtained by two way ANOVA followed by Bonferroni’s post-hoc, ***P < 0.001. (C) Movement velocity
(cm/sec) was calculated (mean ± SEM) over trials during the OFT (15min) for WT (blue; n = 14) and KO (red; n = 20). (D) Bar chart representing the distance traveled
(cm) by WT (blue; n = 14) and KO (red; n = 20) during the OFT. (E) Number of fecal boli (mean ± SEM) counted at the end of the trials. No statistical difference was
observed for the velocity, distance traveled, or fecal boli.
The Latency to Cross to the Dark Box Was
Longer in the Fus1 KO Mice than in the WT
Mice
The main objective of this task is to evaluate the latency of every
mouse to cross from the light to the dark box. In the case of
the WT group (n = 14), they spent 4.2 ± 0.9 s crossing from
the light to the dark box. Interestingly, the Fus1 KO mice (n =
21) spent 11.8 ± 2.1 s, an increase in latency in comparison to
the WT group (one-tailed unpaired Student’s t-test P = 0.003,
Figure 7A).
Both theWT and Fus1 KO spent more time in the dark than in
the light boxes (Figure 7B; WT 228± 21 s in the dark, 9.4± 1.8 s
in the light, P < 0.001; Fus1 KO 246 ± 14 s in the dark, 8 ± 1.1 s
in the light, P < 0.001). No differences were observed between
groups [F(1, 66) = 0.69, P = 0.4, two-way ANOVA] in the total
time spent in the light or the dark boxes (P > 0.99).
Finally, the number of fecal boli was counted for each
group at the end of the test, no differences were observed
between WT (2.3 ± 0.5 boli) and the Fus1 KO (2.0 ± 0.4
boli; one-tailed unpaired Student’s t-test P = 0.32, Figure 7C).
We conclude that anxiety levels did not differ between the
groups as the total time in the dark and the number of
boli was the same, despite a difference in latency (which
is generally considered a less robust anxiety measure than
total time).
Fus1 KO Mice Were Able to Learn the
Passive Avoidance Test
In this test, mice learn to avoid an environment in which
an aversive stimulus (foot-shock) was previously delivered
(dark compartment). During this behavioral test, the WT mice
illustrated a statistical difference in latency crossing from the light
to the dark compartment over the three experimental days after
foot-shock, increasing their time from the first trial to the last
[F(1.49, 19.32) = 197.4, P < 0.0001, one-way RM ANOVA, N = 14,
Figure 8A], showing differences in latency from the first day (14
± 4 s) compared to the second day (287 ± 11 s, P < 0.0001) and
the sixth day (285± 16 s, P < 0.0001).
The Fus1 KO mice also demonstrated changes in latency,
increasing their time from the first to the last days [F(1.91,38.31)
= 129.1, P < 0.0001, one-way RM ANOVA, N = 21, Figure 8A]
and showing differences from the first trial (36± 14 s) compared
with the second day (291 ± 9 s; P < 0.0001) and the sixth
day (274 ± 16; P < 0.0001). We did not find differences in
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FIGURE 7 | The dark-light box test. (A) Bar chart illustrating the initial latency (in seconds) of WT (blue; n = 14) and Fus1 1 KO (red; n = 21) groups to cross from
the light box to the dark box. Significant latency group difference denoted by (ϕ) unpaired one-tailed students t-test, P < 0.01. (B) Bar chart illustrating total time spent
(sec, mean ± sem) by WT (blue; n = 14) and Fus1 1 KO (red; n = 21) in the light and dark box. Both groups spent more time (and each of similar amount) in the dark
than in the light box (two way ANOVA, ***P < 0.001). (C) Number of fecal boli (mean ± SEM) counted at the end of the trials.
the latency between the groups [F(1, 98) = 0.256, P = 0.61,
two-way ANOVA].
This test also measures emotional stress by way of the number
of fecal boli after every trial. The WT group showed an increase
in the number of fecal boli over the trials [F(1.49, 19.31) = 23.55,
P < 0.0001, one-way RM ANOVA, N = 14, Figure 8B] with
statistical differences on the first trial (2.6 ± 0.3 boli) compared
to the second trial (5.5± 0.3 fecal boli; P < 0.0001), and the third
trial (4.6± 0.3 fecal boli; P = 0.0004).
The Fus1 KO also did not show an increase in the number of
fecal boli over the trials [F(1.58,31.58) = 3.42, P = 0.06, one-way
RM ANOVA, N = 21, Figure 8B]. We found differences in boli
between groups [F(1, 98) = 7.94, P = 0.006, two-way ANOVA,
Figure 8B] in the second day of the task (P = 0.002). We
conclude that as latencies did not differ, there was no difference in
associative memory between the groups. Meanwhile, in this test
Fus1 KO mice may have been less anxious than WT.
Fus1 KO Mice Show Impairment in the
Cookie Test
This test measures how fast the animals can find a familiar piece
of chocolate cookie that is hidden in a corner underneath a layer
of bedding, but in different locations between the 2 days. The
WT group showed a difference in the latency to finding the
cookie over 2 days [2 trials/day; R2 = 0.1, P = 0.01, slope −13.5
s/trial; F(2.0, 26.04) = 5.2, P = 0.01, RM one-way ANOVA, N =
14, Figure 9A]. The time was significantly reduced on the second
trial of the day 1 (260± 16 s) compared to the second trial of the
day 2 (175 ± 27 s, P = 0.003). Further, the intra-day averages in
latency between day 1 (252 ± 14 s) and day 2 (186 ± 28 s) were
significant (one-tailed paired t-test P = 0.006, Figure 9B).
In contrast, the Fus1 KO mice did not show statistical
difference in the latency over trials [R2 = 0.01, P = 0.34,
F(2.5, 47.51) = 1.137, P = 0.34, RM one-way ANOVA, N =
20, Figure 9A]. Additionally, the intra-day averages of latency
from day 1 (246 ± 15 s) compared to day 2 (238 ± 19 s)
were not significant (one-tailed paired Student’s t-test P = 0.32,
Figure 9C). In conclusion, Fus1 KO mice did not improve their
odor guided foraging, in contrast to WT mice.
Fus1 KO Mice Showed a Low Performance
in the Training Sessions of the Morris
Water Maze Compared to the WT Mice
To know if the Fus1 KO mice have learning and memory
impairments we tested them using the Morris water maze task,
in which the animals were trained to find the platform quadrant
during four consecutive days followed by a final test day without
the platform, recording the latency to the correct quadrant. The
WT mice reduced their swimming velocity over the training
sessions [R2 = 0.38, P < 0.0001, slope−1.5 cm/s/day; F(1.86, 24.17)
= 7.86, P = 0.003, one-way RM ANOVA N = 14, Figure 10A]
showing a significant reduction between the first day (14.4 ±
0.7 cm/s) compared to the last day of the training (9.5± 0.9 cm/s;
P = 0.005).
Further, the control group also reduced their distance traveled
during the training days [R2 = 0.75, P < 0.0001, slope
−239.6 cm/day; one-way RM ANOVA F(2.02, 26.32) = 39.24, P <
0.0001, Figure 10B], showing statistical differences on the first
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FIGURE 8 | Passive avoidance test. (A) Shows the latency (sec, mean ± SEM) of crossing from the light to the dark box prior to a foot shock (Day 1) and post-foot
shock (day 2 and 6) by the WT (blue) and Fus1 KO (red). Significant difference between latency of day 2 and 6 compared with day 1 was performed using one way
RM ANOVA followed by Bonferroni’s post-hoc, ***P < 0.001. (B) Differences in the number of fecal boli (mean ± SEM) on the first day (before the foot shock)
compared with the second and sixth day of the test (after foot shock) for the WT (blue) and Fus1 KO (red). Two way ANOVA followed by Bonferroni’s post-hoc, ϕϕ,**p
< 0.01, ***P < 0.001, was performed between groups.
day of the session (1030 ± 85.8 cm) compared with the second
day (519.5 ± 71 cm; P = 0.0003), third day (336.6 ± 38.3 cm;
P < 0.0001) and the last day (292.8± 38.7 cm; P < 0.0001).
Finally, the WT were able to reduce their latency to the
platform (R2 = 0.47, P < 0.0001, slope −11.28 s/day; F(1.94, 25.15)
= 11.54, P= 0.0003, one-way RMANOVA, Figure 10C] showing
statistical differences from the first day of training (60.9 ± 4.6 s)
compared with the third day (29.9± 3.7; P = 0.002), and the last
day (27.6± 3.4 s; P = 0.0002).
The velocity observed for the Fus1 KO was also reduced
during the session training [R2 = 0.76, P < 0.0001, slope −2.59
cm/s/day, F(2.78, 49.97) = 57.72, P< 0.0001, one-way RMANOVA,
N = 19, Figure 10A], showing a significant reduction from the
first day (15.4± 0.6 cm/s) compared with the second day (11.2±
0.7 cm/s; P < 0.0001), the third day (9.03± 0.6 cm/s; P < 0.0001)
and the last session (7.5± 0.6 cm/s; P < 0.0001). We did not find
differences in velocity between WT and KO groups [F(1, 121) =
3.14, P = 0.08].
The distance traveled by the Fus1 KO animals was also
reduced during the sessions (R2 = 0.61, P < 0.0001, slope
−294 cm/day, F(2.13, 38.32) = 28.32, P < 0.0001, one-way RM
ANOVA, Figure 10B], and was evident from the first day (1555
± 124.7 cm) compared with the second day (907.7± 124.2 cm; P
= 0.0006), the third day (726± 73.6 cm; P < 0.0001) and the last
day (635.2± 79.7 cm; P < 0.0001). However, we found statistical
differences between WT and KO groups comparing each day of
the training sessions, in which the WT traveled less distance over
the training days in comparison to the KO group [F(1, 121) =
38.78, P< 0.001, two-way ANOVA followed by Bonferroni’s post-
hoc P < 0.001 first day, P = 0.02 second day, P = 0.01 third day,
P = 0.04 fourth day, Figure 10B].
The most pronounced difference between the WT and Fus1
KO mice was recorded in latency (time from start to goal). Fus1
KO mice did not reduce their latency over the training sessions
[R2 = 0.09, P = 0.12; F(2.49, 44.7) = 1.8, P = 0.17, one-way RM
ANOVA, Figure 10C]. We found statistical differences in latency
betweenWT and Fus1 KO groups on all training days [F(1, 124) =
70.91, P < 0.001, two-way ANOVA, post-hoc: first day WT =
60.88 ± 4.7 s vs. Fus1 = 96.6 ± 6.8 s, P = 0.006; second day WT
= 42.7 ±7 .1 s vs. Fus1 = 80.1 ± 9.4 s, P = 0.002; third day WT
= 30± 3.8 s vs. Fus1= 83.2± 7.6 s, P < 0.001; fourth day WT=
27.6± 3.4 s vs. Fus1= 82.5± 9.6 s, P < 0.001, Figure 10C].
Figure 10D shows the latency of all training trials per day. The
WT group reduced their latency across the trials [R2 = 0.22, P <
0.001, slope −2.9 s/trial; F(5.57, 72.37) = 3.81, P = 0.002, one-way
RMANOVA], showing the first statistical difference in the second
trial of the third day (23.8± 2.9 s) compared with the first trial on
day one (76.8 ± 12.4 s; P = 0.01). Unlike WT, the Fus1 KO mice
did not show statistical differences in the latency over the trials
[F(6.88, 123.9) = 0.98, P = 0.44].
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FIGURE 9 | The hidden cookie test. (A) Illustrates the latency (sec; mean ± SEM) of the WT blue; n = 14 and Fus1 KO (red; n = 20) to find the hidden piece of
cookie buried within bedding over two consecutive days 2 trials per day. One way RM ANOVA followed by Bonferroni’s post-hoc, **P < 0.01. (B) The average latency
(sec) of trials compared over 2 days for WT animals. Paired one-tailed students t-test, *P < 0.05. (C) The average latency (sec) of trials compared over 2 days for Fus1
1 KO animals.
Figure 11 shows the data from the 4 days of training trials
illustrating the averaged swimming velocity, traveled distance,
and latency for both groups. Average swimming velocity of WT
(11.7 ± 0.6 cm/s) and KO (10.8 ± 0.5 cm/s) groups showed
no statistical differences between groups (unpaired one-tailed
Student’s t-test P = 0.12, Figure 11A). In contrast, Fus1 KO
mice traveled on average a longer distance of 958 ± 76 cm than
the WT mice (538 ± 34 cm; unpaired one-tailed Student’s t-test
P < 0.0001, Figure 11B). Moreover, the Fus1 KO animals spent
more time finding the platform (86 ± 4 s) compared with the
WT (40.3 ± 3 s; unpaired one-tailed Student’s t-test P < 0.0001,
Figure 11C). To illustrate the differences described above, we
show the four swimming paths from the first day of training from
aWTmouse (Figure 11D) and a KOmouse (Figure 11E). While
the WT was able to learn the site of the platform, and therefore
decreased its distance traveled and latency to the platform over
trials, the Fus1 KO mouse did not show any differences, showing
difficulty to learn the spatial memory task.
Fus1 KO Mice Showed a Low Performance
in the Test Day of the MWM Task
On the test day (locating a quadrant without platform), the Fus1
KO traveled a shorter distance (1053± 93.2 cm) than the control
group (1648 ± 75.7 cm; unpaired one-tailed Student’s t-test P <
0.0001, Figure 12A). The velocity of the KO (8.9 ± 0.08 cm/s)
was less than the background (13.91 ± 0.6 cm/s; unpaired one-
tailed Student’s t-test P < 0.0001, Figure 12B). Additionally, the
latency to the platform quadrant of the Fus1 KO of 77.4 ± 9.7 s
was greater than that of theWT (35.7± 5.6 s; unpaired one-tailed
Student’s t-test P = 0.001, Figure 12C). Further, the WT group
visited the NW quadrant significantly more frequently (13.7 ±
0.9) than the Fus1 group (5.8± 0.8; unpaired one-tailed Student’s
t-test P < 0.0001, Figure 12D).
Inspection of the paths suggested that the Fus1 KO mice
showed thigmotaxis (“wall-hugging”) during the last day of the
task. To analyze this, we divided the maze (91 cm ID, 4163 cm2)
into a center with 80% of the total ID (72.8 cm ID, 4163 cm2,
64% of total area) and remainder as the periphery (36% of total
maze area). We found that the Fus1 mice spent less time in
the center of the maze (46.9 ± 6%) compared with the WT
[84.2 ± 4.2%; two-way ANOVA, F(1, 62) = 45.15, P < 0.0001,
followed by Bonferroni’s post-hoc P < 0.0001]. Further, the Fus1
group spent more time in the periphery of the maze (53.1 ± 6%)
compared with the WT (15.8 ± 4.2%, P < 0.0001). Further, the
WT spent less time in the periphery than expected by chance
(P < 0.001; one-tailed paired t-test vs. 36%), while the KO
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FIGURE 10 | Morris water maze training. (A) Shows the swimming velocity (cm/sec) of WT (blue; n = 14) and Fus1 1 KO (red; n = 19) over 4 days of training.
Significance is determined by a change in velocity compared with day 1. One way RM ANOVA followed by Bonferroni’s post-hoc, *P < 0.05, **P < 0.01, ***P < 0.001.
Both WT and KO decreased their swimming velocity. (B) Illustrates the swimming distance (cm) of WT (blue; n = 14) and Fus1 1 KO (red; n = 19) over 4 days of
training. Significance is determined by a change in velocity compared with day 1. One way RM ANOVA followed by Bonferroni’s post-hoc, ***P < 0.001. Differences
between groups shown as ϕP < 0.05, ϕϕϕP < 0.001, two way ANOVA. Both groups decreased their distance however, overall Fus1 KO traveled further across training
days. (C) Demonstrates the latency to find the hidden platform by the WT (blue; n = 14) and Fus1 1 KO (red; n = 19) over 4 training days. (*) represents a significant
decrease in latency (sec) to find the platform, one way RM ANOVA followed by Bonferroni’s post-hoc, *P < 0.05, ***P < 0.001. groups are represented as (ϕ) ϕϕP <
0.01, ϕϕϕP < 0.001, two way ANOVA. (D) This figure shows the latency (sec) of WT (blue) and Fus1 1 KO (red) to find the hidden platform in the NW quadrant over
four consecutive trials performed during the four training days. The WT not Fus1 KO mice, were able to reduce their latency over trials; one way RM ANOVA followed
by Bonferroni’s *P < 0.05, ***P < 0.001. Differences between groups were evident over training days, two way ANOVA followed by Bonferroni’s post-hoc, ϕP < 0.05,
ϕϕϕP < 0.001. WT were able to reduce their latency over the training sessions, but the Fus1 KO mice did not show differences between training days.
mice spent more time in the periphery than expected by chance
(P < 0.006, Figure 12E). This observation bears out the KO’s
impairments to remember a specific location since the platform
was always inside the center zone during the training days. To
illustrate the above, we show a swimming path from aWTmouse
(Figure 12F) which spent more time in the NW quadrant and
in the center of the maze, trying to find the platform (P). On
the other hand, the KO mouse looked disoriented (Figure 12G),
with a simple thigmotaxic navigation path, with no evident sign
to remember the location of the P, and spending more time in
the periphery of the maze. Interestingly, thigmotaxis was not
evident in the open field test for either group. In conclusion,
the Fus1 KO mice showed clear evidence of impaired spatial
memory.
Fus1 KO Mice Did Not Show Alterations in
the Nestlet Building, but Did Show
Sleep/Awake Disturbances Compared to
the WT Group
The nestlet building test measures the capacity of the mice to
construct a nest. BothWT andKOmice scored similarly high (4.8
± 0.09 vs. 4.8 ± 0.07) on this test without statistical difference
(unpaired one-tailed Student’s t-test P = 0.28, WT N = 14,
Fus1 KO N = 19, Figure 13A). We show in Figures 13B,C
examples of nest building by a WT and KO mouse after 24 h
at the end of the test we did not find any differences between
groups.
However, in the sleep/awake test during two dark and light
cycles (Figure 14A), the Fus1 KO spent a larger fraction of time
asleep during the dark cycle of the first day (41 ± 2% asleep vs.
WT 29 ± 2%, unpaired one-tailed Student’s t-test P = 0.0001)
and the second day (47 ± 2% asleep vs. WT 39 ± 2%, unpaired
one-tailed Student’s t-test P = 0.003), and in the light cycle of
the second day (56 ± 1% vs. WT 51 ± 2%, unpaired one-tailed
Student’s t-test P = 0.007). With respect to the time spent asleep
across the 2 days (Figure 14B), we found statistical differences in
the dark cycle (WT 35.3 ± 1.9% asleep vs. Fus1 KO 44.3 ± 1.6%,
unpaired one-tailed Student’s t-test P = 0.001), and in the light
cycle (WT 56.9± 1.3% asleep vs. Fus1 KO 61.7± 0.9%, unpaired
one-tailed Student’s t-test P = 0.003).
Fus1 KO Mice Show Alterations in Energy
Homeostasis, Antioxidant, Autophagy, PKC
and Calcium Signaling Proteins in the
Olfactory Bulb and (or) Hippocampus
In order to comprehend the molecular basis of early alterations
in olfactory memory, spatial memory, and sleep commonly
associated with aging but identified in 5 months old Fus1 KO
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FIGURE 11 | The average Morris water maze training performance. (A) The average of swimming velocity (cm/sec) over the 4 days training between WT (blue)
and Fus1 1 KO (red). (B) The average distance traveled (cm) over the 4 days of training between WT (blue) and Fus1 1 KO (red). Significant group difference was
shown using unpaired students t-test, ϕϕϕP < 0.001. (C) The average latency to find the hidden platform performed over 4 training days. The Fus1 KO showed higher
latency than the WT group, ϕϕϕP < 0.001. (D,E) Illustrate representative heat maps of the swimming paths of a WT and Fus1-KO mouse during four trials of the first
training day. It is evident that the WT mouse reduced its swimming distance over trials since was able to learn the zone in which the platform was submerged. In
contrast, the KO mouse did not decrease its distance and hence did not learn the specific platform zone.
mice, we performed immunoblot analysis of olfactory bulbs (OB)
and hippocampi (HP) focusing on aging-associated pathways.
Equal amounts of OB or HP protein lysates extracted from four
mice per group were pooled together to obtain sufficient amounts
of protein for multiple immunoblots and to compensate for
possible inter-individual heterogeneity within a group.Moreover,
to make the analysis even stricter, only changes that showed
more than 30% difference between WT and KO samples were
taken into consideration. The most pronounced difference that
we identified in our analysis were changes in the AMPK (5′
AMP-activated protein kinase)/ACC (Acetyl CoA carboxylase)
pathway, which regulates cellular energy homeostasis. We
showed that both OB and HP of 5 months old KO mice
have lower levels of ACC2 protein (9.1- and 2.38-fold decrease,
respectively). ACC2 is an enzyme that produces malonyl-CoA
molecule, which negatively regulates the β-oxidation of fatty
acids. Thus, decreased level of ACC2 can lead to an increased
use of fatty acids for energy (ATP) production, which may result
in several negative consequences for brain functioning that will
be discussed later. At the same time, we found that ACC1, an
enzyme involved in fatty acid synthesis and usually present only
in lipogenic tissues in contrast to ACC2, which is predominant
in oxidative tissues (Kreuz et al., 2009), is drastically increased
in Fus1 KO OBs (16.7-fold increase relative to WT) suggesting
an increased need for fatty acids in Fus1 KO OBs. Activated
AMPK is the negative regulator of ACC, thus we measured
the phosphorylation levels of AMPK (phospho-index, a ratio
of phosphorylated and total proteins). Both Fus1 KO OB and
HP tissues have higher levels of AMPK phosphorylation (2.17-
and 14.3-fold increase in P-index, respectively), which suggest
decreased activities of ACC in both tissues.
We also found that antioxidant protection of OB and HP
tissues in KO mice is deficient based on the low levels of PRDX1,
one of the main antioxidant enzymes (2.46- and 4.73-fold
decrease, respectively). The autophagy marker LC3-II showed a
decrease in both tissues (1.83-fold decrease in OB and 3.27-fold
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FIGURE 12 | Morris water maze test day. (A) Represents distance traveled (cm) by WT (blue) and Fus1 1 KO (red). The WT traveled further than the Fus1 KO,
unpaired one-tailed student t-test, ϕϕϕP < 0.001. (B) Shows the reduction in velocity (cm/sec) of the Fus1 KO (red) compared to WT mice (blue) unpaired one-tailed
student t-test, ϕϕϕP < 0.001. (C) Illustrates the latency (sec) of WT (blue) and Fus1 1 KO (red) to swim to the platform location in the NW quadrant on test day during
two consecutive trials. Fus1 KO displayed greater latency to the area unpaired one-tailed student t-test, ϕϕP < 0.01. (D) Dot plot showing the number of times the
WT crossed into the NW quadrant compared to the KO mice (the zone in which the platform was submerged during the training sessions). Unpaired one-tailed
students t-test, ϕϕϕP < 0.001. (E) Depicts the total time (expressed as percentage) that the groups of mice spent in the center or periphery of the water maze on the
last day of the test. The WT group spent more time in the center compared to the Fus1 KO, two-way ANOVA followed by Bonferroni’s post-hoc, ***P < 0.0001. (F,G)
Show heat maps of the swimming path of two mice, WT and Fus1 KO, on the fifth day of the MWM test without the platform. Note the swimming path of the WT
mouse that shows frequent visits to the NW quadrant; in contrast the Fus1 KO mouse path does not show a clear preference for the NW quadrant and has less
complex movements, suggesting disorientation.
decrease in HP), pointing to an early onset of autophagy
dysregulation in Fus1 KO mice. We did not find differences in
the apoptotic marker Bcl-xL between WT and Fus1 KO tissues.
We also analyzed the levels of four proteins representing
pathways involved in memory formation, synaptogenesis and
aging-associated memory loss. TrkB (BDNF receptor) and NGFR
(p75NTR) showed no differences, however, Calretinin and
RACK1 levels were lower in the HP of Fus1 KO mice (3.83-
and 1.58-fold decrease, respectively), though no differences were
observed in OB tissues. The significance of these findings is
presented in the Discussion section below.
DISCUSSION
The majority of current animal models of AD express human
genes containing mutations associated with familial AD (fAD).
fAD is not common, representing only the 5% of AD cases (Irvine
et al., 2008). In contrast, the sporadic AD (sAD) represents 95% of
the remaining AD population. However, creatingmodels for sAD
has been more challenging due to the complex factors (genetics,
physiology, age, diet, physical activity, exposure to environmental
hazards, etc.) that interact to cause sAD (Onos et al., 2016). It
is well known that age is a high risk factor for developing sAD
(Gatz et al., 2006). Aging is itself related to the production of
free radicals and it has been proposed that excess of free radicals
may contribute to amyloid beta aggregation (Christen, 2000).
In the present work, we introduce the Fus1 KO mouse as a
novel model for sAD that combines premature aging, chronic
oxidative stress due to high ROS production and inadequate
anti-oxidant machinery, mitochondrial dysfunction, low grade
chronic inflammation and aberrant acute inflammatory response
(Ivanova et al., 2007; Uzhachenko et al., 2012, 2014; Hood et al.,
2013). This model is highly relevant to sAD as increased ROS
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FIGURE 13 | (A) Nestlet building test. Scores (Goate et al., 1991; Levy-Lahad
et al., 1995; Sherrington et al., 1995; Piaceri et al., 2013; Kumar et al., 2015)
defining the construction of nestlet, 1 is an intact nestlet and 5 indicates a
nestlet torn over 90% and with a clear crater. WT and Fus1 KO were able to
build the nest and did so with no significant difference in their total score. (B,C)
Show the similar nest building capacities of a WT and a Fus1 KO mouse,
showing well-defined nestlet craters.
generation and oxidative damage occur early in the progress of
sAD. In fact, oxidative stress may be involved in the pathogenesis
of most neurodegenerative disorders (Gandhi and Abramov,
2012). Taken together, the alleviation of oxidative stress
represents a potential therapeutic approach for slowing sAD (Di
Matteo and Esposito, 2003). Here, we have demonstrated that
relatively young Fus1 KOmice develop primary aging-associated
alterations related to olfactory memory, spatial memory and
sleep.
Ranging from Warner’s smell identification studies testing
patients at different stages of disease (Warner et al., 1986),
to the olfactory experiments testing transgenic animal models
for AD (Coronas-Sámano et al., 2014; Roddick et al., 2016), it
has been proposed that there is a decrement in the ability to
identify, discriminate and remember a wide variety of odorants.
Interestingly, while Fus1 KO animals showed somewhat poor
long-term odor memory compared to their WT counterparts,
short-term memory was not clearly adversely affected. Two
different mechanisms govern habituation memory in mice across
the two different timescales (McNamara et al., 2008; Wilson
and Linster, 2008; Freedman et al., 2013). The habituation to
novel olfactory stimuli is preceded by a complex process of
odor recognition whereby olfactory sensory neurons within the
nose form glutamatergic synapses on mitral cells which project
into the olfactory cortex, principally the piriform cortex, then
to the basolateral amygdala. These mitral cells are themselves
glutamatergic and target pyramidal cells that express N-methyl
d-aspartate (NMDA) and non NMDA metabotropic receptors
(Shipley and Ennis, 1996). Antagonists of the metabotropic
receptor have been shown to reduce odor habituation via mitral
cell projections to the piriform cortex for short term behavioral
odor adaptation. In contrast, long term habituation is localized
within the olfactory bulb is affected by the NMDA antagonist
MK-801 either by systemic injection or introduced locally to
the olfactory bulb (McNamara et al., 2008). Therefore, odor
habituation over short ITIs is mediated by synaptic adaptation
in the piriform cortex by the activation of metabotropic
glutamate receptors, which has been shown to persist briefly
(ca. 2 min) and is highly odor specific. In contrast, habituation
over longer ITIs is dependent on the NMDA receptor, is
localized primarily within the bulb, lasts for at least 20min,
and is not odor specific (McNamara et al., 2008). Habituation
persistence studies across either short or long time scales have
also shown increased exploration time for as long as 60min
post-presentation of an odor (Freedman et al., 2013). Therefore,
the differences shown between habituation over short and long
time frames in Fus1 KO mice suggests an underlying Fus1-
dependent alteration in the habituation mechanism within the
olfactory bulb. Fus1 is highly expressed with the olfactory bulb
(http://biogps.org/#goto=genereport&id=80385) and within the
cerebral cortex which hence does not explain the moderate
differences between the short and long term memory defects
observed at this young age. The ability to perform the STM
task suggests that it is not an alteration in perception of
odor but rather a reduction in memory duration as the ITI’s
were increased. The formation and expression of habituation
memory from the olfactory bulb is modulated by noradrenergic
projections from the locus coeruleus (LC). Studies have
shown that lesioning cortical noradrenergic fibers can eliminate
habituation to the same odors, which can be rescued by the
infusion of noradrenalin into the olfactory bulbs (Guérin et al.,
2008). Noradrenalin has been shown to drastically reduce levels
of reactive oxygen species suggesting that it acts as an antioxidant.
It is rapidly degraded in this process as it is primarily protective
via its metabolites (Troadec et al., 2001). This suggests that
within our animal model the excessive ROS production may
be decreasing OB noradrenergic levels which are important for
habituation memory.
Yang and Crawley illustrate the animal’s natural tendency to
use olfactory cues during buried food tests that can be used
to evaluate their ability to smell volatile odors, assuming that
if mice fail to locate the food, they are likely to have deficits
in their olfactory abilities (Yang and Crawley, 2009). Moreover,
Kulkarni et al. (2012) hypothesized that evolution favored
the olfactory system and its connections to the hippocampus
and limbic cortex providing rodents a guide to resources of
calorie rich food in their environment. This affects multiple
areas besides the primary olfactory system, including areas
associated with learning and memory and the processing of
emotional stimuli: forebrain cortex, insular cortex, hippocampus,
nucleus accumbens, anterior thalamic nucleus (Kulkarni et al.,
2012). Here we have shown that the Fus1 KO animals can
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FIGURE 14 | The sleep/awake test. (A) Comparison of the percentage of sleep observed in the WT and Fus1 KO mice during two dark and light cycles. The Fus1
KO displayed a higher percentage of sleep compared to the WT. (B) Shows the percentage of time the animals were asleep during 2 days for each cycle, which
differed between groups during both the dark and light cycles. Paired one-tailed students t-test, **P < 0.01, ***P < 0.001.
perform the hidden cookie test over a short time frame,
however, when these animals are tested again 24 h later no
improvement in their performance was observed unlike the
WT animals, which displayed a decrease in time taken to
find the food reward. The difficulty of Fus1 KO animals to
perform the task, however, does not reflect a motivational deficit,
as they did not show alterations in the nest building test,
whereby high levels of motivation are required to construct an
evolutionary beneficial living environment (Jirkof, 2014). They
also were not different from WT mice in the sucrose preference
test, which is indicative of anhedonia. Experiments mapping
post-training memory consolidation during an odor–reward
association task, illustrated the involvement of the amygdala
and the prefrontal cortex (PFC), both of which also highly
express Fus1 (http://biogps.org/#goto=genereport&id=80385).
The amygdala has been shown to be important during odor
discrimination tasks in concert with the PFC (Schoenbaum
et al., 1999). Furthermore, the role of the PFC for long-term
memory formation has also been demonstrated during food
odor association tasks (Bouret and Sara, 2004; Tronel et al.,
2004; Carballo-Márquez et al., 2007). In addition, the important
role of the amygdala in inhibitory avoidance learning has been
widely demonstrated (Wilensky et al., 2000; Canal et al., 2008).
Interestingly, our results demonstrate defects during the odor
reward tasks but not during inhibitory avoidance. These results
show that despite the overlapping brain regions involved in the
olfactory based memory tasks and association memory tasks,
defects are only shown for tasks requiring olfaction. Taken
together, our results suggest that the mitochondrial dysfunction-
mediated increased levels of ROS and low-grade inflammation
in young Fus1 KO model of the olfactory-based deficits correlate
with precognitive decline associated with sAD.
Long term stress can contribute significantly to cognitive
impairment. Hence, emotional symptoms such as anxiety
and depression (anhedonia) were other key parameters for
investigation as they contribute significantly to the clinical profile
Frontiers in Aging Neuroscience | www.frontiersin.org 18 November 2016 | Volume 8 | Article 268
Coronas-Samano et al. Fus1 KO Mice Model sAD
in mild cognitive impairment and AD. There was no clear
evidence during any test investigating emotional disturbances
that Fus1-deficent mice display these symptoms, except for
significantly increased latency to cross from the light to the dark
box at the beginning of the experiment. This difference in time on
crossing from the light box to an unfamiliar environment (dark
box) could be a first sign of neophobia (initial tendency to avoid
a novel environment) (Bourin and Hascoët, 2003).
Fus1-deficent animals display deficits in spatial memory
observed by poor performance during the Morris water maze
compared to WT counterparts. The MWM has been frequently
utilized to determine cognitive deficits in AD animal models
(Bromley-Brits et al., 2011; Baeta-Corral and Gimenez-Llort,
2015), and it has been useful to study hippocampal-dependent
learning including short- and long-term spatial memory. Indeed,
mice with hippocampal lesions cannot perform the task. Here,
we showed that the Fus1 mice were impaired to learn the specific
zone of the maze in which the platform was hidden. The last
was evident when the Fus1 mice were not able to decrease their
latency to find the platform during four subsequent trials over the
training days. When we compared the swimming paths between
groups, the KO pathways tended to be less complex compared to
the background.
Moreover, deficits in hippocampal learning and memory have
been shown to be linked to oxidative stress associated with aging
(Huang et al., 2015). ROS have been shown to adversely affect
synaptic plasticity (reviewed in Massaad and Klann, 2011). Since
Fus1 is highly expressed in the hippocampus, its loss could
result in severe hippocampal oxidative stress (high ROS level
and low antioxidant PRDX1 level, Figure 15), thus adversely
affecting spatial memory in Fus1 KO mice. The MWM has been
frequently utilized to determine cognitive deficits in AD animal
models (Sun et al., 2006; Qing et al., 2008). It has been previously
demonstrated that aged rats have increased latency to learn the
MWM compared to young animals and have decreased retention
for the task learned. In addition, young rats fed a vitamin E
deficient diet, which results in a defect in their antioxidant
capacity, also display inadequate task performance and memory
retention compared to control rats of the same age (Fukui
et al., 2001). In addition, animals subjected to hypoxia-induced
oxidative stress show a reduction in the MWM performance in
both young and old mice, which could be alleviated with vitamin
E supplementation (Fukui et al., 2002). Changes in diet leading
to iron deficiency and dysregulation of manganese has also
shown increased oxidative stress markers leading to behavioral
deficits in the MWM (Fitsanakis et al., 2009). As discussed, the
hippocampus and the olfactory system are required to facilitate
the guidance of animals toward food sources. Therefore, the clear
deficit observed in hippocampus-dependent tasks suggests that
hippocampus may have also played a role in the deficits observed
in the hidden cookie task presented in the Fus1 KO mice.
Finally, sleep is critical for the proper function of many
organ systems, particularly the brain. The sleep-awake cycle
synchronized to the light-dark cycle is the most obvious example
of circadian process. Studies suggest that sleep and circadian
disturbances likely occur very early in the disease process and
may contribute to the pathogenesis of AD. The association
between sleep and learning including olfactory-based learning
has been demonstrated (Rasch et al., 2007; Barnes and Wilson,
2014). Certain stages of sleep that can be divided into slow wave
sleep (SWS), rapid eye movement (REM) and non-rapid eye
movement (nREM) have been illustrated to play different roles
in memory consolidation during different types of memory tasks
(Walker and Stickgold, 2004; Rauchs et al., 2005). Changes in
sleep patterns were evident during this study as Fus1 KO mice
displayed an increase in the amount of sleep regardless of the light
or dark cycle compared to WT animals. However, this increase
in sleep time does not appear to be beneficial for the memory-
based task performance presented here. Hence it remains to be
determined whether these mice have altered sleep stages, which
may cause the changes in memory consolidation.
To pinpoint the molecular basis of cognitive alterations in
young Fus1 KO mice, we analyzed the primary brain regions
involved in olfactory memory; olfactory bulbs and hippocampus.
The olfactory bulb processes the olfactory stimuli which then
projects to the hippocampus a key area for learning and memory
formation. Based on the biology of the Fus1 protein (Uzhachenko
et al., 2012, 2014, 2015; Yazlovitskaya et al., 2013, 2015) and
on aging-associated pathways involved in cognitive decline, we
included in the analysis the proteins representing pathways
linked to (1) energy homeostasis (ACC1, ACC2, AMPK); (2)
oxidative stress (PRDX1); (3) apoptosis and autophagy (Bcl-xL,
LC3); (4) learning andmemory (TrkB, NGFR, Calretinin, Rack1).
The most consistent alterations observed in both tissues were
of the proteins regulating energy homeostasis and anti-oxidant
machinery, allowing us to consider dysregulation of energy
homeostasis and oxidative stress as the primary pathological
events in Fus1 KO mice.
Significant decrease in the levels of ACC2, a negative
regulator of fatty acid β-oxidation, combined with increased
phosphorylation index of AMPK, that suppresses activities
of ACC2 suggest that Fus1 KO olfactory bulbs (OB) and
hippocampus (HP) use fatty acid oxidation for ATP production
at a much higher levels than WT tissues. Moreover, consistent
with this notion, we showed that Fus1 KO OB also have higher
levels of ACC1 protein that is responsible for biosynthesis
of fatty acids suggesting higher needs by Fus1 KO olfactory
bulbs for fatty acids. Increased fatty acid oxidation, most
likely, is a compensatory mechanism for inefficient oxidative
phosphorylation machinery in Fus1 KO mitochondria
(Uzhachenko et al., 2014, and unpublished data) allowing
brain tissues to have sufficient energy to survive and function.
However, favoring fatty acids oxidation as a source of energy
in Fus1 KO brain tissues could result in several disadvantages
considering that in general brain metabolism favors glucose
oxidation over burning of fatty acids for energy production
(Schonfeld and Reiser, 2013). There are several reasons for
that: (1) ATP generation linked to β-oxidation of fatty acids
demands more oxygen than glucose, thereby enhancing the risk
for neurons to become hypoxic; (2) β-oxidation of fatty acids
generates superoxide, which, taken together with the poor anti-
oxidative defense in neurons, causes increased oxidative stress. In
the case of Fus1 KO, considering perpetually high levels of ROS
in these cells due to mitochondrial dysfunction (Uzhachenko
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FIGURE 15 | Western blot analysis of aging-related proteins in the olfactory bulbs and hippocampi of 5-month old WT and Fus1 KO mice. Proteins
involved in energy homeostasis, antioxidant machinery, autophagy, apoptosis, and brain activities were analyzed in the olfactory bulbs and hippocampi of 5-month old
WT and Fus1 KO mice by Western blot and are presented as a relative expression or phosphorylation index. The numbers to the right of each western blot panel
represent the fold change in protein expression in the WT relative to the KO. All band intensity levels were normalized to a corresponding β-actin level. Phosphorylation
index (P-index) is the ratio of phosphorylated protein intensity over total protein band intensity. Only changes that showed more than 30% difference between WT and
KO samples were taken into consideration and shown as numbers in black as opposed to numbers in gray.
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et al., 2012, 2014; Yazlovitskaya et al., 2015) and low levels of
antioxidant PRDX1 in HP and OB tissues (Figure 15), using fatty
acids for ATP production in Fus1 KO brain tissues may create
such severe oxidative stress that it would be incompatible with
normal tissue functioning and result in multiple disturbances
on molecular, cellular and behavioral levels; (3) the rate of
ATP generation based on adipose tissue-derived fatty acids is
lower than that using blood glucose as fuel. Thus, in periods of
extended continuous and rapid neuronal firing, that happens,
among other cases, during memory formation, fatty acid
oxidation cannot guarantee rapid ATP generation in neurons
(Schonfeld and Reiser, 2013), therefore, learning and long term
memory may be compromised as we found in Fus1 KO mice.
Interestingly, in both OB and HP of Fus1 KO mice we
also observed decreased levels of the autophagy marker LC3-II.
Autophagy is responsible for the recycling of long-lived proteins
and organelles that are either damaged (e.g., mitochondria) or
functionally redundant and is crucial for the maintenance of
cellular homeostasis in all eukaryotic cells. The primary role of
autophagy is to protect cells against stress (Moreau et al., 2010).
During autophagy a cytosolic form of LC3 (LC3-I) is converted
via conjugation to phosphatidylethanolamine to LC3-II, which
is recruited to autophagosomes. High levels of LC3-II reflect a
higher autophagy rate and vice versa. Defects in the activation of
autophagy are involved in the pathogenesis of AD (Wolfe et al.,
2013; Nixon, 2014), thus we suggest that defective autophagy is
one of the several of molecular mechanisms playing a detrimental
role in early cognitive decline of Fus1 KO mice.
We also found that expression of two proteins, RACK1
(receptor for activated C-kinase 1) and Calretinin (Calb2) is
downregulated in HP but not in OB of Fus1 KO animals.
RACK1 is an anchoring protein that shuttles activated PKC to
cellular membranes, plays an important role in PKC-mediated
signal transduction pathways (Mochly-Rosen et al., 1991). It is
ubiquitously expressed in the brain, especially at higher levels in
memory related brain areas, such as the hippocampus, cortex,
and cerebellum (Ashique et al., 2006). It has been reported that
expressions of RACK1 were significantly decreased in the brain
of aging animals and AD patients (Battaini et al., 1999; Van
der Zee et al., 2004). Calretinin (Calb2) is a calcium-binding
protein that is expressed principally in neurons (Rogers, 1987).
It has an important role as a modulator of neuronal excitability
including the induction of long-term potentiation, the basis of
learning and memory (Camp and Wijesinghe, 2009). Calretinin
is also involved in presynaptic signaling as a mobile calcium
buffer/transporter capable of regulating calcium signaling over
nanometer distances at presynaptic sites (Edmonds et al., 2000).
Calretinin interneurons are early targets of extracellular amyloid-
beta pathology in the hippocampus of Alzheimer mouse models
(Baglietto-Vargas et al., 2010). Thus, taken the importance of
these two proteins in neuronal activities, we suggest that Fus1-
dependent decrease in RACK1 and calretinin plays a detrimental
role in cognitive activities of these mice.
Interestingly, two other proteins that we analyzed, TrkB and
NGFR, which also are closely involved in memory formation
and in normal development and survival of neurons in the
peripheral and central nervous systems (Vickland et al., 1991;
Mizuno et al., 2003), did not show any difference between WT
and KO. This suggests that Fus1 loss affects specific neuronal
pathways associated with calcium and PKC signaling.
Fus1 affects a wide range of proteins, the mechanism of which
is only partially known. Fus1 is a nuclear-encoded,mitochondria-
residing small globular protein with a yet unknown biochemical
activity. We found that it is a putative calcium-binding
protein that regulates mitochondrial and cellular calcium fluxes
(Uzhachenko et al., 2014), ROS production (Uzhachenko et al.,
2012), mitochondrial dynamics (Uzhachenko et al., 2014), and
efficiency of anti-oxidant machinery (Yazlovitskaya et al., 2013,
2015, and present manuscript). Importantly, Fus1 KO cells have
low mitochondrial respiratory reserve (manuscript submitted),
which means they cannot produce additional ATP/energy
in response to stimuli or stress. Thus, loss of Fus1 may
alter expression/phosphorylation of genes/proteins that are
modulated by calcium, ROS or ATP levels as well as by oxidative
stress, which we showed in this study (Figure 15) and our other
studies (Ivanova et al., 2007; Hood et al., 2013; Uzhachenko et al.,
2014, 2015).
As the olfactory tract projects to the piriform cortex,
amygdala, and hippocampus, which are all severely damaged
in AD, this has led to the “olfactory hypothesis” of AD. It
suggests that the olfactory pathway may be an initial site of
involvement in the disease progression (Mann et al., 1988;
Kovács et al., 2001). This is confirmed by AD degenerative
changes observed within the olfactory bulb, tract and anterior
olfactory nucleus (Powell et al., 1963; Pearson et al., 1985).
Although sAD and fAD present with clinical phenotypes that
are very similar, their molecular mechanisms differ substantially
as genetic mutations are not the singular cause of sAD. The
reason for amyloid accumulation and aggregation therefore,
remains to be fully elucidated. Consequently, transgenic mouse
models alone are insufficient to investigate sAD etiology and
pathogenesis (Lecanu and Papadopoulos, 2013). Transgenic
approaches used to investigate AD rely on the ectopic expression
of themutated human genes, such as APP/PS1 and APP/Tau, that
drive fAD but are not representative of the underlying pathology
of sAD, which is more prevalent in the population (Borchelt
et al., 1997; Lewis et al., 2001). As such approaches only model
the amyloidogenesis hypothesis of AD pathology, novel tools are
required to investigate sAD in vivo.
The large array of tests used here to characterize the Fus1
KO mouse required careful design. In order to minimize the
influence of one test on the next and to avoid manipulating
the aging process the following features were integrated. First,
we avoided tests that require food or water regulation which
may affect homeostasis, stress and the aging process. Hence
all tests are “spontaneous.” Second, the more stressful tests
(MWM and passive avoidance) were implemented near the
end of the test set (Figure 1). Third, hypothermic stress
of the classic MWM was reduced by elevating the water
temperature from room temperature to midway (29◦C) between
room (21◦C) and body temperature (37◦C). Fourth, 2 days
of rest was provided between tests. This was a compromise
between increasing the inter-test interval for increased test
independence and decreasing the overall duration of the test set
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(2 months) to assess behavioral abilities within a narrow age
range.
Recently, another promising non-transgenic rodent model
for investigating central insulin resistance has been described.
This model involves the administration of streptozotocin-
intracerebroventricularly (STZ-icv) to rats to induce pathological
similarities to those observed in sAD patients. These rats
demonstrate cognitive deficits at 2 weeks post-administration
and last for 12 weeks or longer irrespective of the animal age
at the time of administration. This subsequently results in
oxidative stress 1 week after treatment, 2 weeks before the
memory deficits were observed (Salkovic-Petrisic and Hoyer,
2007). Insulin resistance both centrally and peripherally is a
severe risk factor for sAD. Since the olfactory bulb has the
brain’s highest Insulin Receptor (IRs) density (Unger et al., 1989)
and the fastest insulin transport of any brain region (Banks,
2004), it is the most susceptible to central insulin-resistance.
As oxidative stress (Butterfield, 2004), changes in the glucose
metabolism, cholinergic system, accumulation of tau and
beta-amyloid (Grünblatt et al., 2007), tau hyperphosphorylation,
neuroinflammation (Weinstock and Shoham, 2004), and
learning and memory dysfunctions are all induced by central
insulin resistance, it suggests that the alteration in the OB
function is a key early indicator of sAD, which is consistent with
the data presented here based on the Fus1 KO mouse model.
It could be argued that the Fus1 KO model, showing clear
early life cognitive deficits due to a single genetic event, a loss of
Fus1, may not represent sAD’s multifactorial long-term etiology.
Admittedly, it is a difficult task to distinguish between genetic
and other factors playing principal roles in the AD etiology,
especially considering that no Fus1 mutational analysis in AD
patients were performed to date. However, based on our earlier
work (Ivanova et al., 2009; Uzhachenko et al., 2012), which
showed that Fus1 mRNA level is decreased during ROS exposure,
inflammation, and exposure to infection agents, we suggest that
Fus1 levels may be regulated epigenetically. Therefore, during
chronic conditions that create oxidative stress such as systemic
inflammation, or during chronic exposure to environmental
hazards, Fus1 mRNA levels may be permanently low, causing
chronic mitochondrial dysfunction and consequently early aging
and aging-associated pathologies including cognitive deficit.
Considering the principal role of mitochondrial bioenergetics
in neurodegenerative diseases including AD (Johri and Beal,
2012), here we demonstrate that loss/decrease of Fus1 may
cause olfactory and spatial memory changes early in life,
which are paralleled by molecular changes in the functionally
relevant olfactory bulb and hippocampus. However, we propose
that deleterious changes in mitochondrial function caused by
Fus1 loss do not immediately result in neurodegeneration and
cognitive deficits. This process is rather cumulative in nature and
occurs over time, and therefore analogous to spontaneous AD. It
consists of (a) an initial period, when no negative consequences
of Fus1 loss are noticed due to, most likely, innate compensatory
mechanisms; (b) the middle reversible period (the age is 4–5
months old) when the first signs of neurodegeneration could be
revealed, and (c) the final, irreversible period (after 11–12months
of age), that is characterized by severe neurodegeneration and
lack of plasticity.
We further note that only a subset of the large behavioral
test set showed statistically significant decline, most of them of
only mild degree at this relatively young age. This parallels the
disease progression of sAD which begins with olfactory deficits
followed by onset of mild cognitive impairments. These striking
parallels between the Fus1 KO model and sAD lend credit to
the mitochondrial cascade hypothesis of sAD. It will hence be
of great interest to explore the Fus1 KO deficits into senescence.
We also suggest that during the first two aforementioned
periods the mitochondrial and neurodegenerative changes
may be alleviated/corrected by nutraceutical or pharmaceutical
intervention that potentiates mitochondrial bioenergetics. This
hypothesis will be addressed in our future studies.
Here we demonstrated clear evidence that our novel Fus1
KO mouse model of mitochondrial dysfunction and oxidative
stress can be used for the detection of early olfactory memory
deficits and spatial memory deficits in young animals and is
an excellent alternative mouse model to the classical transgenic
animal models of AD.
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